Concepedia

Magda Bahcall

MB

Statistics

Publications

17

Citations

1.8K

H-Index

16

Active since

2015

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

Broad Institute

Magda Bahcall is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2015–2024

17

Publications

17

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Kari J. Kurppa, Yao Liu, Ciric To et al. · Cancer Cell · 2020 · 472 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

Gonzalo Recondo, Magda Bahcall, Liam F. Spurr et al. · Clinical Cancer Research · 2020 · 219 citations

Medicine, Molecular Genetics, Oncology +17

Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)

Chelsea E. Powell, Yang Gao, Li Tan et al. · Journal of Medicinal Chemistry · 2018 · 190 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Acquired <i>MET</i> D1228V Mutation and Resistance to MET Inhibition in Lung Cancer

Magda Bahcall, Taebo Sim, Cloud P. Paweletz et al. · Cancer Discovery · 2016 · 174 citations · Full text

Medicine, Oncology, Pharmacology +17

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 161 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 17